speaker-image

Dr. Ellen R. Strahlman

speaker-image

Strahlman retired as EVP of research & development and chief medical officer of Becton, Dickinson and Company in 2018. Previously, she was senior advisor to the CEO at GlaxoSmithKline. Earlier she held senior executive leadership roles in global product development and medical affairs at Pfizer Inc., Novartis AG, Virogen Ltd., Bausch & Lomb Inc. and Merck & Co. Inc. She currently serves on the board of Syncona Ltd.

  • 2021 First Quarter

Added to: Altria Group Inc. - Richmond, VA

Altria is the parent company of Philip Morris USA Inc. and other operations. Revenues are $21 billion.

See More